Wolverine Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.3M | Sell |
339,800
-113,900
| -25% | -$12.9M | 0.03% | 390 |
|
|
2025
Q2 | $50.2M | Buy |
453,700
+69,400
| +18% | +$7.39M | 0.05% | 253 |
|
|
2025
Q1 | $43M | Buy |
384,300
+58,900
| +18% | +$6.08M | 0.05% | 238 |
|
|
2024
Q4 | $29.9M | Buy |
325,400
+23,800
| +8% | +$2.14M | 0.03% | 353 |
|
|
2024
Q3 | $25.2M | Buy |
301,600
+112,500
| +59% | +$8.58M | 0.03% | 360 |
|
|
2024
Q2 | $13M | Buy |
189,100
+16,000
| +9% | +$1.07M | 0.01% | 537 |
|
|
2024
Q1 | $12.7M | Sell |
173,100
-3,400
| -2% | -$261K | 0.01% | 567 |
|
|
2023
Q4 | $14.3M | Sell |
176,500
-48,400
| -22% | -$3.77M | 0.01% | 576 |
|
|
2023
Q3 | $16.9M | Buy |
224,900
+18,200
| +9% | +$1.4M | 0.02% | 430 |
|
|
2023
Q2 | $15.7M | Sell |
206,700
-84,800
| -29% | -$6.76M | 0.02% | 429 |
|
|
2023
Q1 | $23.7M | Sell |
291,500
-84,800
| -23% | -$7.02M | 0.04% | 305 |
|
|
2022
Q4 | $32.3M | Buy |
376,300
+175,400
| +87% | +$13.9M | 0.05% | 299 |
|
|
2022
Q3 | $12.7M | Sell |
200,900
-29,400
| -13% | -$1.85M | 0.02% | 468 |
|
|
2022
Q2 | $14.4M | Sell |
230,300
-138,500
| -38% | -$8.57M | 0.02% | 406 |
|
|
2022
Q1 | $22M | Buy |
368,800
+58,100
| +19% | +$3.71M | 0.03% | 400 |
|
|
2021
Q4 | $22.8M | Buy |
310,700
+33,800
| +12% | +$2.33M | 0.03% | 427 |
|
|
2021
Q3 | $19.6M | Buy |
276,900
+43,100
| +18% | +$3.03M | 0.02% | 538 |
|
|
2021
Q2 | $15.9M | Sell |
233,800
-48,600
| -17% | -$3.25M | 0.02% | 507 |
|
|
2021
Q1 | $18.5M | Sell |
282,400
-79,200
| -22% | -$5.11M | 0.03% | 424 |
|
|
2020
Q4 | $20.5M | Buy |
361,600
+34,600
| +11% | +$2.09M | 0.03% | 391 |
|
|
2020
Q3 | $20.3M | Buy |
327,000
+57,200
| +21% | +$3.97M | 0.05% | 292 |
|
|
2020
Q2 | $20.1M | Sell |
269,800
-181,100
| -40% | -$13.9M | 0.05% | 251 |
|
|
2020
Q1 | $34.2M | Buy |
450,900
+110,600
| +33% | +$7.64M | 0.1% | 131 |
|
|
2019
Q4 | $22.1M | Buy |
340,300
+124,000
| +57% | +$8.08M | 0.05% | 333 |
|
|
2019
Q3 | $13.6M | Sell |
216,300
-4,400
| -2% | -$288K | 0.04% | 403 |
|
|
2019
Q2 | $14.9M | Sell |
220,700
-13,600
| -6% | -$895K | 0.04% | 380 |
|
|
2019
Q1 | $15.2M | Sell |
234,300
-41,500
| -15% | -$2.76M | 0.04% | 341 |
|
|
2018
Q4 | $17.1M | Buy |
275,800
+26,000
| +10% | +$1.82M | 0.05% | 300 |
|
|
2018
Q3 | $19.3M | Sell |
249,800
-112,800
| -31% | -$8.52M | 0.04% | 317 |
|
|
2018
Q2 | $27.3M | Hold |
362,600
| – | – | 0.07% | 187 |
|
|
2018
Q1 | $27.3M | Buy |
362,600
+27,900
| +8% | +$2.22M | 0.07% | 187 |
|
|
2017
Q4 | $24M | Sell |
334,700
-146,900
| -31% | -$11.2M | 0.09% | 197 |
|
|
2017
Q3 | $39M | Buy |
481,600
+92,200
| +24% | +$7.05M | 0.15% | 106 |
|
|
2017
Q2 | $27.6M | Buy |
389,400
+73,400
| +23% | +$4.88M | 0.13% | 143 |
|
|
2017
Q1 | $21.3M | Sell |
316,000
-14,100
| -4% | -$991K | 0.12% | 170 |
|
|
2016
Q4 | $23.6M | Buy |
330,100
+104,000
| +46% | +$7.73M | 0.12% | 173 |
|
|
2016
Q3 | $17.6M | Buy |
226,100
+68,800
| +44% | +$5.59M | 0.08% | 256 |
|
|
2016
Q2 | $12.9M | Buy |
+157,300
| New | +$14M | 0.07% | 272 |
|
Other funds holding GILD
Wolverine Trading's GILD Position: Q3 2025 in Review
Wolverine Trading increased its Gilead Sciences (GILD) stake by 385% in Q3 2025, buying an estimated $3.68M and bringing the position to 40,825 shares worth $4.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1456.
Wolverine Trading first reported a position in GILD in Q2 2016 and has held it in 37 quarters since. The position peaked at $19.6M in Q4 2017. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Wolverine Trading held 40,825 shares of Gilead Sciences worth $4.6M as of Q3 2025.
- Wolverine Trading bought 32,409 Gilead Sciences shares in Q3 2025, an estimated $3.68M.
- Gilead Sciences made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1456 holding.
- Wolverine Trading first reported a position in Gilead Sciences in Q2 2016 and has held it in 37 quarters since.
- Wolverine Trading's Gilead Sciences position peaked at $19.6M in Q4 2017.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.